The new treatment, known as Leqembi or lecanemab, was approved through an accelerated process. It follows the approval of the anti-Alzheimer's drug Aduhelm, which a US congressional investigation criticized for alleged "irregularities." >>アデュカヌマブは、米議会調査から批判されていたんか。 The two drugs were developed by Ja…